Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acadia Pharmaceutica (NQ: ACAD )

22.15 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 22.15
Bid (Size) 22.13 (4)
Ask (Size) 22.40 (1)
Prev. Close 22.15
Today's Range 22.15 - 22.15
52wk Range 19.20 - 57.46
Shares Outstanding 160,179,036
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that the New England Journal of Medicine published results from the Phase 3 HARMONY study, an international, double-blind, placebo-controlled... 
From Business Wire News Releases
Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter 2021 financial results on Wednesday, August 4, 2021, after the close of the U.S. financial markets.... 
From Business Wire News Releases

Performance

YTD
-58.06%
-58.06%
1 Month
-12.55%
-12.55%
3 Month
+6.64%
+6.64%
6 Month
-54.43%
-54.43%
1 Year
-48.67%
-48.67%

More News

Read More
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – ACAD
From GlobeNewswire News Releases
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Association International Conference 2021 (AAIC)
From Business Wire News Releases
ACAD SHAREHOLDER DEADLINE TOMORROW: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now
From GlobeNewswire News Releases
Acadia Pharmaceuticals is Now Oversold (ACAD)
Tags Stocks
From Market News Video
ACAD September 3rd Options Begin Trading
Tags Stocks
From Market News Video
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From Business Wire News Releases
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Fir
From Business Wire News Releases
First Week of March 2022 Options Trading For Acadia Pharmaceuticals (ACAD)
Tags Stocks
From Market News Video
Understanding ACADIA Pharmaceuticals's Unusual Options Activity
Tags ACAD Options BZI/UOA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]